Summary: Atherosclerosis is driven by endothelial injury and chronic inflammation, not just the presence of cholesterol. By using Cardiogen to physically heal the artery lining and stabilize plaque caps, and BPC-157 to stop the inflammatory attack on the vessel wall, you remove the primary triggers for disease progression. This protocol offers a proactive, root-cause defense against the hardening and narrowing of your arteries.
Standard treatments focus almost exclusively on lowering LDL cholesterol (statins) to remove the building blocks of plaque. A functional peptide protocol focuses on vascular repair and inflammation control. By healing the endothelial injury that starts the process and cooling down the immune response that drives plaque growth, we can stop the body from needing to lay down new plaque and potentially stabilize existing deposits so they are less likely to rupture.
The Endothelial Healer: Cardiogen
Cardiogen is a synthetic tetra-peptide designed to have profound regenerative effects on the cardiovascular system. While its name implies a focus on the heart, its mechanism of action is equally powerful for the vascular endothelium.
- Mechanism: Cardiogen stimulates the proliferation and differentiation of endothelial cells—the cells that make up the inner “wallpaper” of the artery. A healthy, intact endothelium is naturally anti-thrombotic and resistant to plaque; it is “Teflon-coated.” Cardiogen helps repair the microscopic cracks, lesions, and areas of dysfunction where plaque initially gains a foothold.
- Benefits: By physically restoring this protective barrier, Cardiogen prevents the infiltration of LDL particles into the deeper layers of the artery wall (the sub-endothelial space). Furthermore, it promotes the synthesis of healthy collagen scaffolding. This strengthens the “fibrous cap” that covers existing plaque. A thick, strong cap keeps the plaque stable; a thin, weak cap is prone to rupturing and causing a sudden, fatal clot. Cardiogen promotes stability.
The Anti-Inflammatory Shield: BPC-157
Inflammation is the fire that hardens the arteries. BPC-157 is a powerful systemic anti-inflammatory peptide that offers specific protection for the vascular wall.
- Mechanism: BPC-157 works by inhibiting multiple inflammatory pathways, including the release of cytokines like TNF-alpha and IL-6. It prevents the recruitment of monocytes (white blood cells) to the artery wall. In atherosclerosis, these monocytes burrow into the plaque and turn into “foam cells” by eating too much cholesterol. These foam cells then die and release toxic enzymes that destabilize the plaque.
- Benefits: By stopping this immune reaction, BPC-157 slows the active growth of the blockage. Additionally, BPC-157 protects the endothelium from oxidative stress and toxin-induced damage. It acts as a “cytoprotective” shield, keeping the artery wall calm and reducing the chronic, low-grade inflammation that transforms stable plaque into a ticking time bomb.
